Development of Novel Breast Cancer Recurrence Prediction Model Using Support Vector Machine.
10.4048/jbc.2012.15.2.230
- Author:
Woojae KIM
1
;
Ku Sang KIM
;
Jeong Eon LEE
;
Dong Young NOH
;
Sung Won KIM
;
Yong Sik JUNG
;
Man Young PARK
;
Rae Woong PARK
Author Information
1. Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea. veritas@ajou.ac.kr
- Publication Type:Original Article
- Keywords:
Artificial intelligence;
Breast neoplasms;
Neural networks;
Recurrence;
Risk factors
- MeSH:
Artificial Intelligence;
Breast;
Breast Neoplasms;
Estrogens;
Follow-Up Studies;
Hospitals, Teaching;
Humans;
Lymph Nodes;
Recurrence;
Retrospective Studies;
Risk Factors;
Sensitivity and Specificity;
Support Vector Machine
- From:Journal of Breast Cancer
2012;15(2):230-238
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The prediction of breast cancer recurrence is a crucial factor for successful treatment and follow-up planning. The principal objective of this study was to construct a novel prognostic model based on support vector machine (SVM) for the prediction of breast cancer recurrence within 5 years after breast cancer surgery in the Korean population, and to compare the predictive performance of the model with the previously established models. METHODS: Data on 679 patients, who underwent breast cancer surgery between 1994 and 2002, were collected retrospectively from a Korean tertiary teaching hospital. The following variables were selected as independent variables for the prognostic model, by using the established medical knowledge and univariate analysis: histological grade, tumor size, number of metastatic lymph node, estrogen receptor, lymphovascular invasion, local invasion of tumor, and number of tumors. Three prediction algorithms, with each using SVM, artificial neural network and Cox-proportional hazard regression model, were constructed and compared with one another. The resultant and most effective model based on SVM was compared with previously established prognostic models, which included Adjuvant! Online, Nottingham prognostic index (NPI), and St. Gallen guidelines. RESULTS: The SVM-based prediction model, named 'breast cancer recurrence prediction based on SVM (BCRSVM),' proposed herein outperformed other prognostic models (area under the curve=0.85, 0.71, 0.70, respectively for the BCRSVM, Adjuvant! Online, and NPI). The BCRSVM evidenced substantially high sensitivity (0.89), specificity (0.73), positive predictive values (0.75), and negative predictive values (0.89). CONCLUSION: As the selected prognostic factors can be easily obtained in clinical practice, the proposed model might prove useful in the prediction of breast cancer recurrence. The prediction model is freely available in the website (http://ami.ajou.ac.kr/bcr/).
